SY

Sanjay Yashwant Dhumal

Active Director Director DIN 08917614
DIN 08917614 First appointment Oct 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Yashwant Dhumal

Data last updated:

Sanjay Yashwant Dhumal is a Director at Savitee Pharma Chem Private Limited (since 2020). The company operates in Chemicals.

DIN 08917614
Primary Designation Director
Industry Chemicals
First Appointment 13 Oct 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Savitee Pharma Chem Private Limited U24100PN2020PTC194950
Director13 Oct 20202020Active

Board colleagues of Sanjay Yashwant Dhumal

NameDINCompanyDesignation
Sanket Sanjay Dhumal08917615Savitee Pharma Chem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Savitee Pharma Chem Private Limited
Premium access

Shareholding and investment profile for Sanjay Yashwant Dhumal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Yashwant Dhumal

Sanjay Yashwant Dhumal currently holds 1 directorship: Savitee Pharma Chem Private Limited (Director, since 13 Oct 2020).

Sanjay Yashwant Dhumal was first appointed on 13 Oct 2020 as Director at Savitee Pharma Chem Private Limited.

The current boards of Sanjay Yashwant Dhumal's companies include Sanket Sanjay Dhumal (Savitee Pharma Chem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available